Effect of fenfluramine challenge on cocaine craving in addicted male users

American Journal on Addictions

Volumn 7, Issue 2, 1998, Pages 142-155

  Buydens Branchey, Laure ^a   Branchey, Marc ^b   Hudson, Jeffrey ^b   Rothman, Michael ^b   Fergeson, Paul ^b   McKernin, Craig ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; DATA ANALYSIS; DRUG DEPENDENCE; DRUG EFFECT; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; PROLACTIN BLOOD LEVEL; SEROTONIN RELEASE; WITHDRAWAL SYNDROME;

EID: 0031980057     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1521-0391.1998.tb00329.x     Document Type: Article

References (24)

1. UNDCP and WHO Informal Expert Committee on the Drug-Craving Mechanism. Report, United Nations International Drug Control Programme and World Health Organization, Technical Report Series (No. V 92-54439 T), 1992
2. Pickens RW, Johanson CE: Craving: consensus of status and agenda for future research. Drug Alcohol Depend 1992; 30:127-131
3. Buydens-Branchey L, Branchey M, Fergeson P, et al: Craving for cocaine in addicted users: role of serotonergic mechanisms. Am J Addict 1997; 6:65-73
4. Coccaro EF: Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavior relationship. Int Clin Psychopharmacol 1992; 7:9-12
5. Spitzer RL, Williams JB, Gibbon M, et al: User's Guide for the Structured Clinical Interview of the DSM-III-R. Washington, DC, American Psychiatric Press, 1990
6. Murphy DL, Mueller EA, Hill JL, et al: Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-CPP given intravenously or orally to healthy volunteers. Psychopharmacology 1989; 98:275-282
7. Krebs HA, Cheng LK, Wright GH: Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. J Chromatogr Biochem Appl 1984; 310:412-417
8. Suckow RF, Cooper TB, Kahn RS: High-performance liquid chromatographic method for the analysis of plasma m-chlorophenylpiperazine. J Chromatogr 1990; 528:228-234
9. Fuller RW, Snoddy HD: Effect of serotonin-releasing drugs on serum corticosterone concentration in rats. Neuroendocrinology 1980; 31:96-100
10. Fuller RW: Serotonergic stimulation of pituitary-adrenocortical function in rats. Neuroendocrinology 1981; 32:118-127
11. Bagdy G, Calogero AE, Murphy DL, et al: Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 1989; 125:2664-2669
12. Gibbs DM, Vale W: Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophyseal portal blood. Brain Res 1983; 280:176-179
13. Meltzer HY, Maes M: Effect of pindolol pretreatment on MK212-induced plasma cortisol and prolactin responses in men. Biol Psychiatry 1995; 38:310-318
14. Hollander E, Cohen LJ, De Caria C: Timing of neuroendocrine responses and effects of m-CPP and fenfluramine plasma levels in OCD. Biol Psychiatry 1993; 34:407-413
15. Naranjo CA, Brenner KE: Serotonin-altering medications and desire, consumption, and effects of alcohol: treatment implications, in Towards a Molecular Basis of Alcohol Use and Abuse. Edited by Jansson B, Jörnvall H, Rydberg U, et al. Basel, Switzerland, Birkhäuser, 1994, pp 209-219
16. Pollack MH, Rosenbaum JF: Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry 1991; 52:31-33
17. Batki SL, Manfredi LB, Peyton J, et al: Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Pharmacol 1993; 13:243-250
18. Batki SL, Washburn AM, Delucchi K, et al: A controlled trial of fluoxetine in crack-cocaine dependence. Drug Alcohol Depend 1996; 41:137-142
19. Covi L, Hess JM, Kreiter NA, et al: Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse 1995; 21:327-344
20. Grabowski J, Rhoades H, Elk R, et al: Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled, double-blind trials. J Clin Psychopharmacol 1995; 15:163-174
21. Walsh SL, Preston KL, Sullivan JT, et al: Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharmacol. 1994; 14:396-407
22. Howell LL, Byrd LD: Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther 1995; 275:1550-1559
23. Tiffany ST, Singleton E, Haertzer CA, et al: The development of a craving questionnaire. Drug Alcohol Depend 1993; 34:19-28
24. Krystal JH, Webb E, Cooney N, et al: Specificity of ethanol-like effects elicited by serotonergic and noradrenergic mechanisms. Arch Gen Psychiatry 1994; 51:589-911